AIF Gene

AIF Gene

Overview

Pathway Diagram

AIF Gene

Overview

Pathway Diagram

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">AIF Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>AIF</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>AIF</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=AIF" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/huntington" style="color:#ef9a9a">Huntington</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">126 edges</a></td>
</tr>
</table>

AIF ([Apoptosis](/entities/apoptosis) Factor), officially designated AIFM1 (Apoptosis-Inducing Factor Mitochondria-Associated 1), encodes a 67 kDa flavoprotein that serves dual roles as a mitochondrial oxidoreductase essential for oxidative phosphorylation and as a caspase-independent death effector.[@mate2002][@susin1999] Located on chromosome Xq26.1, AIFM1 is X-linked and its loss-of-function mutations cause a spectrum of mitochondrial diseases including severe encephalomyopathy, spondylo-epiphyseal dysplasia, and [Charcot-Marie-Tooth disease](/diseases/charcot-marie-tooth-disease) type 4.[@ghezzi2010] AIF's translocation from mitochondria to the nucleus during cell death mediates large-scale DNA fragmentation and chromatin condensation — a pathway termed parthanatos — that is implicated in neuronal loss after [stroke](/diseases/stroke), excitotoxicity, and in [Parkinson's Disease](/diseases/parkinsons-disease) and [Huntington's Disease](/diseases/huntington-disease).[@susin1999][@culmsee2005]

Structure

AIF is synthesized as a 613-amino-acid precursor with an N-terminal mitochondrial targeting sequence (MTS, aa 1–54) that is cleaved upon import into the intermembrane space (IMS).[@mate2002] The mature 57 kDa form is anchored to the inner mitochondrial membrane via a single transmembrane helix (aa 55–77). The soluble portion folds into three domains:

• FAD-binding domain: Binds flavin adenine dinucleotide (FAD) as a cofactor, conferring NADH oxidase activity essential for mitochondrial respiratory chain function.[@mate2002]
• NADH-binding domain: Catalyzes NADH-dependent electron transfer. The oxidoreductase activity is critical for proper assembly and maintenance of [Complex I](/mechanisms/mitochondrial-complex-i) (NADH:ubiquinone oxidoreductase).[@mate2002][@ghezzi2010]
• C-terminal domain: Contains DNA-binding residues required for the nuclear death effector function. Upon apoptotic cleavage by calpains or cathepsins, a truncated ~57 kDa AIF (tAIF) is released from the membrane and translocates to the nucleus.[@susin1999]

Normal Function

Mitochondrial Bioenergetics

AIF's primary housekeeping function is maintaining mitochondrial respiratory chain integrity. AIF is required for the proper assembly and stability of [Complex I](/mechanisms/mitochondrial-complex-i), the largest enzyme complex in the electron transport chain.[@ghezzi2010][@klein2002] AIF-deficient cells show 50–70% reduction in Complex I activity, impaired oxidative phosphorylation, and a compensatory shift toward glycolytic metabolism.[@ghezzi2010] This bioenergetic function is independent of AIF's apoptotic role and is mediated by its oxidoreductase activity in the mitochondrial intermembrane space.

Redox Balance

AIF functions as a NAD(P)H oxidase that helps regulate cellular redox state. It interacts with the thioredoxin/glutathione antioxidant systems and contributes to mitochondrial [ROS](/entities/reactive-oxygen-species) homeostasis.[@mate2002] Loss of AIF increases mitochondrial superoxide production, creating oxidative stress that further damages respiratory chain components.

Stem Cell Maintenance

AIF plays a role in hematopoietic and neural stem cell function. AIF-deficient (Harlequin) mice develop progressive cerebellar degeneration due to granule cell loss, demonstrating AIF's essential role in post-mitotic neuronal survival.[@klein2002]

Role in Neurodegeneration

Parthanatos: PARP-Dependent Cell Death

The most well-characterized neurodegenerative pathway involving AIF is parthanatos — a cell death mechanism triggered by excessive activation of [PARP-1](/entities/parp1) (poly-ADP-ribose polymerase 1).[@culmsee2005][@wang2011] The signaling cascade proceeds:

Parthanatos is distinct from apoptosis (caspase-dependent) and [necroptosis](/entities/necroptosis) (RIPK-dependent), and PARP inhibitors or AIF knockdown protect [neurons](/entities/neurons) from excitotoxic death in vitro and in vivo.[@culmsee2005][@wang2011]

Stroke and Cerebral Ischemia

AIF nuclear translocation is a major mediator of neuronal death after ischemic stroke.[@culmsee2005] In mouse models of middle cerebral artery occlusion (MCAO), AIF translocates to the nucleus within 2–4 hours of reperfusion. The Harlequin mouse (with ~80% AIF reduction) shows significantly smaller infarct volumes after MCAO, confirming AIF's causal role in ischemic neuronal death.[@culmsee2005][@klein2002]

Parkinson's Disease

In dopaminergic neurons exposed to [MPTP](/entities/mptp)/MPP+ or 6-OHDA, PARP-1 hyperactivation triggers AIF-mediated parthanatos.[@wang2011] PARP-1 knockout mice are protected from MPTP-induced dopaminergic neurodegeneration. AIF nuclear translocation has been detected in substantia nigra neurons of PD patient post-mortem tissue, suggesting this pathway is active in human disease.[@wang2011]

Huntington's Disease

[Mutant huntingtin](/proteins/huntingtin-protein) protein causes oxidative DNA damage that activates PARP-1, leading to AIF release and nuclear translocation in striatal medium spiny neurons.[@wang2004] PARP inhibition rescues neurodegeneration in Huntington's mouse models (R6/2, YAC128), and AIF pathway activation correlates with disease progression.[@wang2004]

AIFM1 Mutations and Mitochondrial Disease

Loss-of-function mutations in AIFM1 cause a spectrum of X-linked mitochondrial disorders characterized by Complex I deficiency, progressive neurodegeneration, and muscle weakness.[@ghezzi2010] Clinical presentations include Cowchock syndrome (X-linked CMT4), infantile-onset encephalomyopathy, and auditory neuropathy. These monogenic disorders demonstrate that AIF's bioenergetic function is essential for neuronal survival independent of its death effector role.

Therapeutic Implications

• PARP inhibitors: Olaparib, veliparib, and other PARP inhibitors already approved for oncology use could potentially be repurposed to block parthanatos in acute neurological injuries (stroke, TBI) and chronic neurodegeneration.[@wang2011]
• AIF translocation blockers: Small molecules that prevent AIF cleavage or its nuclear import (e.g., calpain inhibitors, importin-alpha blockers) are under preclinical investigation.[@culmsee2005]
• Combination targeting: Combining PARP inhibition with antioxidant strategies to reduce upstream DNA damage may provide synergistic neuroprotection.

See Also

• [Apoptosis Pathways](/mechanisms/apoptosis)
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
• [PARP-1](/entities/parp1)
• [Stroke](/diseases/stroke)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Huntington's Disease](/diseases/huntington-disease)
• [Complex I Deficiency](/mechanisms/mitochondrial-complex-i)

External Links

• [UniProt: AIFM1 (O95831)](https://www.uniprot.org/uniprot/O95831)
• [NCBI Gene: AIFM1](https://www.ncbi.nlm.nih.gov/gene/9131)
• [GeneCards: AIFM1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=AIFM1)
• [OMIM: AIFM1](https://www.omim.org/entry/300169)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving AIF Gene discovered through SciDEX knowledge graph analysis: